Venomics AI Raises $2.7 Million to Turn Venom Into Medicine
Bengaluru-based biotechnology startup Venomics AI has raised $2.7 million, or about ₹25.5 crore, in a pre-seed round co-led by Speciale Invest and other backers, as it seeks to use artificial intelligence to accelerate drug discovery from animal venoms. The company is targeting a long-standing scientific challenge: converting highly complex natural toxins into precise therapeutic candidates for diseases with limited treatment options.
